UKS

@UcianeScarlett

Biotech VC. Past life - strategist, biotech operator, cancer immunologist *Views are my own...sometimes borrowed*

Cambridge, MA
Vrijeme pridruživanja: rujan 2017.

Tweetovi

Blokirali ste korisnika/cu @UcianeScarlett

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @UcianeScarlett

  1. 4. velj

    Thanks to all my amazing sponsors & corporate supporters! General tickets are discounted for 1 week, starting today - $250. Get yours HERE --> WSGR, , OSI, Entera Bio, , TSG, LEK, Wuxi Biologics

    Poništi
  2. 29. sij

    Always great collaborating w. Keith Flaherty & Dennis Chang; our In Vivo article from the 2019 Emerging Frontiers event > A Tale Of Two Pipelines :: In Vivo . tickets to 2020 event>

    Poništi
  3. 27. sij

    Late post; points to our growing understanding of MAIT cells...may be too early to implement into existing cell therapy platforms - class of γδ TCR recognize the underside of the antigen-presenting molecule MR1

    Poništi
  4. 26. sij

    Pearl Huang & Doug Williams added; Speakers fr industry, academia, & VC will discuss 2020's topic Feb 25 Developing a Dynamic Bridge Around the Globe to Accelerate Oncology Innovation. Tickets: Sponsor: , , OSI

    , , i još njih 6
    Poništi
  5. 22. sij

    Come hear John Castle, , Keith Flaherty, Geoffrey Kim, Alexis Borisy, Melanie Nallicheri, , Errik Anderson, George Demetri and others at the 2nd Emerging Frontiers in Oncology Feb 25. Get tickets here ->

    , , i još njih 4
    Poništi
  6. 16. sij

    Great time to be in the with OSI – mjesto: Union Square

    Poništi
  7. 8. sij
    Poništi
  8. 7. sij

    So true. Got to know him over the last few months - great loss for the community.

    Poništi
  9. 9. pro 2019.

    Mark your calendars - the 2nd Emerging Frontiers in Oncology is February 25, 2020 Supporting Great speakers lined up for 2020 topic: "Developing a Dynamic Bridge Around the Globe to Accelerate Oncology Innovation"

    , , i još njih 4
    Poništi
  10. 9. pro 2019.

    Fascinating work by Dr. Elisa Oricchio EZH2 inhibitors are TAD switches. Putting into greater therapeutic context 3D chromatin structure with function

    Poništi
  11. 9. pro 2019.

    Large meal at the end of D02 with my amazing teammates was sad he wasn’t allowed to touch the ham leg 🍖 – mjesto: The Ravenous Pig

    Poništi
  12. 31. lis 2019.

    I remember in 2015 trying to predict what this graph would look like 5 years out - consistent label expansions for resulted in 14+ approved indications vs. 10+ for I’m always here for the underdog

    Poništi
  13. 29. lis 2019.

    Great point - While promising, data is pretty early in my opinion. has some room to explore

    Poništi
  14. proslijedio/la je Tweet
    18. lis 2019.

    Welcome David Hoffman, exec dir of IP , to the Everest Base Camp trekking team. 7 spots left on this special expedition to Nepal for cancer research More on -->

    Poništi
  15. proslijedio/la je Tweet
    15. lis 2019.

    Deanna Petersen, our CBO, has worn many hats while pursuing , from license negotiator to headhunter to scout, scouring the world for promising academic programs. Read about her adventures here:

    Poništi
  16. 30. ruj 2019.

    I hope we don’t forget what we learnt with targeted therapies - individual tumors’ driver & passenger mutations matter

    Poništi
  17. 28. ruj 2019.

    Impressive 71% ORR, historically <50% in cis-ineligible 1L aUC PDL1 +ve tumors. Cant tease apart Nectin-4 expression from PDL-1 in this dataset, but clearly might be playing a greater role here.

    Poništi
  18. 23. ruj 2019.
    Poništi
  19. proslijedio/la je Tweet
    8. ruj 2019.

    Highly anticipated update on AMG510 in by Ramaswamy Govindan does not disappoint. High RR (48%, 54% at 960mg) and DCR of 100%! No DLTs! Amazing early data in a huge area of need. – mjesto: Fira Barcelona Gran Via

    Prikaži ovu nit
    Poništi
  20. 23. kol 2019.

    Wow - my experience last month pales in comparison. The lemurs I saw were pretty chill and mostly looked frightened to see my camera pointed at them 😕

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·